This sociological study is the first comprehensive qualitative report on retention rates of the Victorian opioid maintenance treatment (OMT) program. The research was based on surveys and face-to-face interviews with 60 clients currently receiving OMT, of which the majority derived their income from government support and were already considered to be financially vulnerable. This research demonstrated the negative impact of dispensing fees on retention rates, with clients experiencing financial stress as a result of having to pay the dispensing fees. The research analysed the notion of cost from several perspectives, including individuals' social functioning, their health and their ability to remain in treatment. These research finding...
Introduction Prescription charges prevent many people from accessing the medicines they need to main...
Opiate dependence imposes a significant economic burden on society in terms of treatment-related cos...
Rowan Yemm, Christabel Jones, Tryphosa Mitoko Cardiff University School of Pharmacy and Pharmaceutic...
Introduction: Opioid agonist treatment (OAT) clients frequently bear costs associated with their tre...
Introduction and Aims: Australian pharmacotherapy maintenance programs incur costs to patients. Thes...
This study investigates the willing to pay for a Multidose Drug Dispensing System(MDD)in pharmacies....
Background: Opioid substitution therapy (OST) programs involve the dispensing of OST medicines to pa...
BACKGROUND: Out-of-pocket costs for opioid agonist treatment (OAT) constitute a barrier to treatment...
To review the literature regarding the value and consumer focus of research on opioid replacement th...
Rising pharmaceutical expenditures have led to the use of cost-sharing measures. The authors underto...
Background Opioid maintenance treatment (OMT) is the most widely used treatment for opioid dependenc...
Background – Opioid Agonist Therapy (OAT) is considered the most effective form of pharmacological t...
AIMS: To conduct an economic evaluation of the first 6 months' trial of treatment vouchers and case ...
BACKGROUND: Long-acting injectable depot buprenorphine is an important new treatment option for the ...
Objectives Restrictions on retail purchases of pseudoephedrine are one regulatory approach to reduce...
Introduction Prescription charges prevent many people from accessing the medicines they need to main...
Opiate dependence imposes a significant economic burden on society in terms of treatment-related cos...
Rowan Yemm, Christabel Jones, Tryphosa Mitoko Cardiff University School of Pharmacy and Pharmaceutic...
Introduction: Opioid agonist treatment (OAT) clients frequently bear costs associated with their tre...
Introduction and Aims: Australian pharmacotherapy maintenance programs incur costs to patients. Thes...
This study investigates the willing to pay for a Multidose Drug Dispensing System(MDD)in pharmacies....
Background: Opioid substitution therapy (OST) programs involve the dispensing of OST medicines to pa...
BACKGROUND: Out-of-pocket costs for opioid agonist treatment (OAT) constitute a barrier to treatment...
To review the literature regarding the value and consumer focus of research on opioid replacement th...
Rising pharmaceutical expenditures have led to the use of cost-sharing measures. The authors underto...
Background Opioid maintenance treatment (OMT) is the most widely used treatment for opioid dependenc...
Background – Opioid Agonist Therapy (OAT) is considered the most effective form of pharmacological t...
AIMS: To conduct an economic evaluation of the first 6 months' trial of treatment vouchers and case ...
BACKGROUND: Long-acting injectable depot buprenorphine is an important new treatment option for the ...
Objectives Restrictions on retail purchases of pseudoephedrine are one regulatory approach to reduce...
Introduction Prescription charges prevent many people from accessing the medicines they need to main...
Opiate dependence imposes a significant economic burden on society in terms of treatment-related cos...
Rowan Yemm, Christabel Jones, Tryphosa Mitoko Cardiff University School of Pharmacy and Pharmaceutic...